Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00321230Phase 2Completed
Phase 2, open-label, single-arm trial of macrogol in bowel preparation, sponsored by Norgine. Primary endpoint: Overall quality of colonoscopy prep. Started Jan 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00321230.